I
Ishwor Poudel
Researcher at Auburn University
Publications - 16
Citations - 128
Ishwor Poudel is an academic researcher from Auburn University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 3, co-authored 7 publications receiving 28 citations.
Papers
More filters
Journal ArticleDOI
Resveratrol-loaded nanomedicines for cancer applications.
Manjusha Annaji,Ishwor Poudel,Sai H.S. Boddu,Robert D. Arnold,Amit K. Tiwari,R. Jayachandra Babu +5 more
TL;DR: In this paper, the physicochemical properties of resveratrol, the therapeutic potential of nano-formulations, and the anticancer activity of encapsulated nanoparticles on various malignancies such as skin, breast, prostate, colon, liver, ovarian, and lung cancers (focusing on both in vitro and in vivo studies).
Journal ArticleDOI
Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines
TL;DR: This study reports co-delivery of doxorubicin (DOX) and ceramide in a liposomal system in B16BL6 melanoma cell lines for enhanced cytotoxic effects and provides basis for developing a co-Delivery system of DOX and ceramides for lowering the dose and dose-related side effects ofDOX for the treatment of melanoma.
Journal ArticleDOI
Application of Extrusion-Based 3D Printed Dosage Forms in the Treatment of Chronic Diseases.
Manjusha Annaji,Sindhu Ramesh,Ishwor Poudel,Manoj Govindarajulu,Robert D. Arnold,Muralikrishnan Dhanasekaran,R. Jayachandra Babu +6 more
TL;DR: This review focuses on the various extrusion-based3D printing technologies such as fused deposition modeling, pressure-assisted microsyringe, and direct powder extrusion 3D printing in the preparation of customizable, multi-drug dosage forms for treating chronic diseases.
Journal ArticleDOI
Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells.
Ahmed Al Saqr,Ahmed Al Saqr,Mohammed F. Aldawsari,Mohammed F. Aldawsari,Hamad Alrbyawi,Hamad Alrbyawi,Ishwor Poudel,Manjusha Annaji,Vanisree Mulabagal,Modukuri V. Ramani,Subbaraju Gottumukkala,Amit K. Tiwari,Muralikrishnan Dhanasekaran,Peter Panizzi,Robert D. Arnold,R. Jayachandra Babu +15 more
TL;DR: Co-delivery of hispolon and doxorubicin using a liposomal system in B16BL6 melanoma cell lines for synergistic cytotoxic effects was investigated and could be a promising therapeutic approach to improve clinical outcomes against melanoma.
Journal ArticleDOI
Elucidating the anti-melanoma effect and mechanisms of Hispolon.
Ahmed Al Saqr,Mohammed Majrashi,Hamad Alrbyawi,Manoj Govindarajulu,Ayaka Fujihashi,Subbaraju Gottumukkala,Ishwor Poudel,Robert D. Arnold,R. Jayachandra Babu,Muralikrishnan Dhanasekaran +9 more
TL;DR: Hispolon dose-dependently exhibited the antimelanoma effect similar to the well established pharmacological agent, curcumin, which can be a potent anti-melanoma drug in the future if the pharmacodynamic effects and the toxicological studies are appropriately carried out.